Lāʻau Palekana ʻAspirin

Wehewehe Pōkole:

Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o nā polymorphisms ma ʻekolu mau loci genetic o PEAR1, PTGS1 a me GPIIIa i nā hāpana koko holoʻokoʻa kanaka.


Nā kikoʻī huahana

Nā Lepili Huahana

Inoa huahana

Pahu ʻIke Lāʻau Palekana HWTS-MG050-Aspirin (Fluorescence PCR)

ʻAlapia

ʻO ka ʻAspirin, ma ke ʻano he lāʻau anti-platelet aggregation kūpono, ua hoʻohana nui ʻia i ka pale ʻana a me ka mālama ʻana i nā maʻi cardiovascular a me cerebrovascular. Ua ʻike ʻia ma ke aʻo ʻana ua ʻike ʻia kekahi mau maʻi ʻaʻole hiki ke kāohi pono i ka hana o nā platelets ʻoiai ka hoʻohana ʻana i ka aspirin haʻahaʻa lōʻihi, ʻo ia hoʻi, ke kūʻē ʻana i ka aspirin (AR). ʻO ka helu ma kahi o 50%-60%, a he ʻokoʻa lāhui maopopo. He kuleana koʻikoʻi ko Glycoprotein IIb/IIIa (GPI IIb/IIIa) i ka hōʻiliʻili platelet a me ka thrombosis koʻikoʻi ma nā wahi o ka ʻeha vascular. Ua hōʻike ʻia nā haʻawina he kuleana koʻikoʻi ko nā polymorphisms gene i ke kūʻē ʻana i ka aspirin, e kālele nui ana i nā polymorphisms gene GPIIIa P1A1/A2, PEAR1 a me PTGS1. ʻO GPIIIa P1A2 ke gene nui no ke kūʻē ʻana i ka aspirin. Hoʻololi nā mutations i loko o kēia gene i ke ʻano o nā mea loaʻa GPIIb/IIIa, e hopena ana i ka pilina ma waena o nā platelets a me ka hōʻiliʻili platelet. Ua ʻike ʻia ma ke aʻo ʻana ua ʻoi aku ka nui o ke alapine o nā alleles P1A2 i nā poʻe maʻi kūʻē i ka aspirin ma mua o nā poʻe maʻi i loaʻa ka aspirin, a ʻo nā poʻe maʻi me nā mutations homozygous P1A2/A2 he haʻahaʻa ka hopena ma hope o ka lawe ʻana i ka aspirin. ʻO nā poʻe maʻi me nā alleles P1A2 mutant e hana ʻia ana i ka stenting he subacute thrombotic event rate ʻelima mau manawa o nā poʻe maʻi P1A1 homozygous wild-type, e koi ana i nā dosis kiʻekiʻe o ka aspirin e hoʻokō i nā hopena anticoagulant. Pane maikaʻi ka allele PEAR1 GG i ka aspirin, a ʻo nā poʻe maʻi me ka genotype AA a i ʻole AG e lawe ana i ka aspirin (a i ʻole i hui pū ʻia me clopidogrel) ma hope o ka hoʻokomo ʻana o ka stent he kiʻekiʻe ka myocardial infarction a me ka make. Loaʻa i ka genotype PTGS1 GG kahi pilikia kiʻekiʻe o ke kūʻē ʻana i ka aspirin (HR: 10) a me kahi hanana kiʻekiʻe o nā hanana cardiovascular (HR: 2.55). Loaʻa i ka genotype AG kahi pilikia kūpono, a pono e uku pono ʻia ka hopena o ka lāʻau aspirin. ʻOi aku ka maʻalahi o ka genotype AA i ka aspirin, a haʻahaʻa ka hanana o nā hanana cardiovascular. Hōʻike wale nā ​​​​hopena ʻike o kēia huahana i nā hopena ʻike o nā genes PEAR1, PTGS1, a me GPIIIa kanaka.

Nā Palena ʻenehana

Ka Waihona

≤-18℃

Ola papa 12 mahina
ʻAno Laʻana ʻUhi ʻāʻī
CV ≤5.0%
LoD 1.0ng/μL
Nā Mea Hana Pili Pili i ka mea hana ʻike ʻano I:

Nā ʻōnaehana Biosystems i hoʻopili ʻia 7500 Nā ʻōnaehana PCR Manawa Maoli,

QuantStudio®5 mau ʻōnaehana PCR Manawa Maoli,

Nā ʻōnaehana PCR Manawa Maoli SLAN-96P (Hongshi Medical Technology Co., Ltd.),

Nā ʻōnaehana ʻike PCR manawa maoli ʻo LineGene 9600 Plus (FQD-96A, ʻenehana Hangzhou Bioer),

MA-6000 Mea Hoʻopololei Wela Manawa Maoli (Suzhou Molarray Co., Ltd.),

ʻŌnaehana PCR Manawa Maoli BioRad CFX96,

ʻŌnaehana PCR Manawa Maoli BioRad CFX Opus 96.

Pili i ka mea hana ʻike ʻano II:

ʻEudemonaTMʻO AIO800 (HWTS-EQ007) na Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.

Kahe Hana

ʻO ka Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006C, HWTS-3006B)) na Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.

ʻO ka nui o ka hāpana i unuhi ʻia he 200μL a ʻo ka nui o ka elution i manaʻo ʻia he 100μL.


  • Ma mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou